000 | 01841 a2200553 4500 | ||
---|---|---|---|
005 | 20250516090202.0 | ||
264 | 0 | _c20121106 | |
008 | 201211s 0 0 eng d | ||
022 | _a1520-636X | ||
024 | 7 |
_a10.1002/chir.22020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhao, Ming | |
245 | 0 | 0 |
_aStereoselective metabolism of tetrahydropalmatine enantiomers in rat liver microsomes. _h[electronic resource] |
260 |
_bChirality _cMay 2012 |
||
300 |
_a368-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBerberine Alkaloids _xchemistry |
650 | 0 | 4 | _aCytochrome P-450 CYP1A2 |
650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xmetabolism |
650 | 0 | 4 | _aCytochrome P-450 CYP3A Inhibitors |
650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 |
_aCytochromes _xantagonists & inhibitors |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aFluvoxamine _xpharmacology |
650 | 0 | 4 | _aHaplorhini |
650 | 0 | 4 |
_aKetoconazole _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred ICR |
650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 | _aSubstrate Specificity |
650 | 0 | 4 |
_abeta-Naphthoflavone _xpharmacology |
700 | 1 | _aLi, Li-Ping | |
700 | 1 | _aSun, Dong-Li | |
700 | 1 | _aSun, Si-Yuan | |
700 | 1 | _aHuang, Shan-Ding | |
700 | 1 | _aZeng, Su | |
700 | 1 | _aJiang, Hui-Di | |
773 | 0 |
_tChirality _gvol. 24 _gno. 5 _gp. 368-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/chir.22020 _zAvailable from publisher's website |
999 |
_c21716602 _d21716602 |